Early research (Phase 1)Study completedNCT00979173What this trial is testingPharmacokinetics (PK) Study of AC480 for Recurrent GliomaWho this might be right forGlioma Annick Desjardins 5
Early research (Phase 1)Study completedNCT00968240What this trial is testingSuper-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)Who this might be right forGlioblastoma MultiformeAnaplastic Astrocytoma Northwell Health 30
Testing effectiveness (Phase 2)Study completedNCT00613093What this trial is testingPh. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant GliomaWho this might be right forGlioblastoma MultiformeAnaplastic Glioma Duke University 67
Testing effectiveness (Phase 2)Study completedNCT00002639What this trial is testingSuramin in Treating Patients With Recurrent Primary Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Emory University
Testing effectiveness (Phase 2)Ended earlyNCT02758366What this trial is testingProlonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine GliomaWho this might be right forGlioblastoma (GBM)DIPGBrainstem Glioma, Pediatric+5 more Meyer Children's Hospital IRCCS 21
Early research (Phase 1)Study completedNCT01922076What this trial is testingAdavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine GliomasWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaDiffuse Intrinsic Pontine Glioma+3 more National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT01250470What this trial is testingVaccine Therapy and Sargramostim in Treating Patients With Malignant GliomaWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+5 more Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00671970What this trial is testingPhase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)Who this might be right forGlioblastomaGliosarcoma Duke University 57
Testing effectiveness (Phase 2)Ended earlyNCT03727841What this trial is testingMarizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord EpendymomaWho this might be right forAnaplastic EpendymomaEpendymomaEpendymomas National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT00036894What this trial is testingCC-5013 in Treating Patients With Recurrent GliomaWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI)
Very early researchLooking for participantsNCT04135807What this trial is testingImplantable Microdevice In Primary Brain TumorsWho this might be right forGrade II GliomaGrade III GliomaGrade IV Glioma+5 more Oliver Jonas 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03919071What this trial is testingDabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade GliomaWho this might be right forAnaplastic AstrocytomaAnaplastic Astrocytoma, Not Otherwise SpecifiedAnaplastic Ganglioglioma+5 more National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Not applicableStudy completedNCT00255671What this trial is testingAcute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersWho this might be right forBrain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity Case Comprehensive Cancer Center 76
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT01164189What this trial is testingBevacizumab in Recurrent Grade II and III GliomaWho this might be right forCentral Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 155
Early research (Phase 1)Study completedNCT00611728What this trial is testingPh I SU011248 + Irinotecan in Treatment of Pts w MGWho this might be right forGlioblastoma Duke University 25
Not applicableWithdrawnNCT00005790What this trial is testingPerfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT05278208What this trial is testingLutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsWho this might be right forHigh Grade GliomaMeningiomaEmbryonal Tumor+10 more Nationwide Children's Hospital 65
Early research (Phase 1)Study completedNCT01480050What this trial is testingMibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent GliomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28